Tacrolimus Market Size, Share, Industry Growth, trends & Forecast to 2027

Global Tacrolimus Market Size, Share, Growth, Industry Trends, Competitive Analysis and Forecast to 2030

Report ID: RC30978 | Report Format: PDF + Excel | Starting Price: 3600/- USD | Last Updated: April 15th, 2023

The global tacrolimus market size is expected to grow at a significant CAGR of around 4.5% during the forecast period 2021 to 2027 and is projected to reach around USD 3.4 billion by 2027. The increasing number of organ transplants around the globe is a primary factor to drive the market growth. According to the latest information shared by HRSA, approximately 39,000 transplants were performed in 2020 in the USA, and in every 9 minutes, a person is added to the waiting list for the organ transplants. Furthermore, the growing prescription of tacrolimus to treat eczema and psoriasis around the world is another factor to fuel the market growth over the forecast period.

Report Attributes:

Benchmark Year		2022
Market Size
Market Growth (CAGR)		4.5% (2023-2030)
Largest Market Share
Analysis Period		2020-2030
Market Players		Astellas Pharma, Inc, Mylan Pharmaceutical Industries Limited, GlaxoSmithKline, Plc, Glenmark Pharmaceuticals Ltd, and Teva Pharmaceutical Industries Limited

Market Insights:

The global tacrolimus market is bifurcated into clinical application, distribution channel, and geography. On the basis of clinical application, the market is further segmented into immunosuppressant, dermatology, and others. The immunosuppressant segment is accounted to hold the largest market share in 2020. The segment growth is attributed to the increasing number of organ transplants across the globe. According to the latest information shared by the World Health Organization (WHO), around 100,800 solid organ transplants performed every year across the globe. Furthermore, the increasing incidence of autoimmune diseases is further supporting the market growth over the forecast period.

Moreover, the dermatology segment is expected to grow at a significant growth rate over the forecast period due to the increasing incidence of skin complications globally. According to the latest information shared by National Psoriasis Foundation (NPF), around 125 million people are suffering from psoriasis across the globe. As per the European Society for Medical Oncology (ESMO), 1% to 3% population is affected by eczema around the world.

Tacrolimus Market Size and Forecast

To know more about the study, request sample papers

The tacrolimus comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Historical & Forecast Period

2018-19 – Historical Year
2020 – Base Year
2021-2027 – Forecast Period

Market Segmentation:

By Clinical Application:

Immunosuppressant
Dermatology
Others

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Others

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Geographic Coverage:

Geographically, the tacrolimus market report comprises dedicated sections centering on the regional market revenue and trends. The tacrolimus market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The tacrolimus market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Tacrolimus market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Competition Assessment:

Key players operating in the global tacrolimus market are Astellas Pharma, Inc, Mylan Pharmaceutical Industries Limited, GlaxoSmithKline, Plc, Glenmark Pharmaceuticals Ltd, and Teva Pharmaceutical Industries Limited. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

Astellas Pharma, Inc
Mylan Pharmaceutical Industries Limited
GlaxoSmithKline, Plc
Glenmark Pharmaceuticals Ltd
Teva Pharmaceutical Industries Limited
Hoffman La-Roche
Reddy’s Laboratories Ltd.
Sandoz, Inc.
Chiesi Farmaceutici.
Abbott Laboratories, Inc.

Key Questions Answered by Tacrolimus Market Report:

Global tacrolimus market forecasts from 2021-2027
Regional tacrolimus market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
Tacrolimus submarket forecasts from 2021-2027 covering the market by clinical application, by distribution channel, and geography
Various industry models such as SWOT analysis, Value Chain Analysis pertaining to tacrolimus market
Analysis of the key factors driving and restraining the growth of the global, regional and country-level tacrolimus markets from 2021-2027
Competitive Landscape and market positioning of top 10 players operating in the tacrolimus market

Table of Content:

1. Preface

1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

2. Executive Summary

2.1. Global Tacrolimus Market Portraiture
2.2. Global Tacrolimus Market, by Clinical Distribution Channel, 2020 (USD Mn)
2.3. Global Tacrolimus Market, by Distribution Channel, 2020 (USD Mn)
2.4. Global Tacrolimus Market, by Geography, 2020 (USD Mn)

3. Global Tacrolimus Market Analysis

3.1. Tacrolimus Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

4. Global Tacrolimus Market By Clinical Distribution Channel, 2018 – 2027 (USD Mn)

4.1. Overview
4.2. Immunosuppressant
4.3. Dermatology
4.4. Others

5. Global Tacrolimus Market By Distribution Channel, 2018 – 2027 (USD Mn)

5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. Others

6. North America Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

6.1.1. Overview
6.1.2. North America Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
6.1.3. North America Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
6.1.4. North America Tacrolimus Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.2. Canada

7. Europe Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

7.1.1. Overview
7.1.2. Europe Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
7.1.3. Europe Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
7.1.4. Europe Tacrolimus Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.2. U.K.
7.1.4.3. France
7.1.4.4. Italy
7.1.4.5. Rest of Europe

8. Asia Pacific Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

8.1.1. Overview
8.1.2. Asia Pacific Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
8.1.3. Asia Pacific Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
8.1.4. Asia Pacific Tacrolimus Market by Country (2018-2027 USD Mn)
8.1.4.1. China.
8.1.4.2. Japan
8.1.4.3. Rest of Asia Pacific

9. Latin America (LATAM) Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

9.1.1. Overview
9.1.2. Latin America Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
9.1.3. Latin America Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
9.1.4. Latin America Tacrolimus Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.2. Mexico
9.1.4.3. Rest of Latin America

10. Middle East and Africa Tacrolimus Market Analysis and Forecast, 2018 – 2027 (USD Mn)

10.1.1. Overview
10.1.2. MEA Tacrolimus Market by Clinical Distribution Channel (2018-2027 USD Mn)
10.1.3. MEA Tacrolimus Market by Distribution Channel (2018-2027 USD Mn)
10.1.4. Middle East and Africa Tacrolimus Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.2. Rest of MEA

11. Company Profiles

11.1. Astellas Pharma, Inc.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Mylan Pharmaceutical Industries Limited
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. GlaxoSmithKline, Plc
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. Glenmark Pharmaceuticals Ltd
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Teva Pharmaceutical Industries Limited
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. F.Hoffman La-Roche
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Dr. Reddy’s Laboratories Ltd.
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Sandoz, Inc.
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Chiesi Farmaceutici.
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Abbott Laboratories, Inc.
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis

To know more about the study, request sample papers

List of Tables:

TABLE 1 Market Snapshot: Global Tacrolimus Market

TABLE 2 Impact Indicators

TABLE 3 Impact Analysis of Drivers and Challenges

TABLE 4 Global Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 5 Global Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 6 North America Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 7 North America Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 8 North America Tacrolimus Market Value, By Country, 2018 - 2027 (US$ Mn)

TABLE 9 U.S. Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 10 U.S. Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 11 Canada Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 12 Canada Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 13 Europe Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 14 Europe Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 15 Europe Tacrolimus Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 16 Germany Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 17 Germany Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 18 U.K. Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 19 U.K. Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 20 France Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 21 France Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 22 Italy Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 23 Italy Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 24 Rest of Europe Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 25 Rest of Europe Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 26 Asia Pacific Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 27 Asia Pacific Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 28 Asia Pacific Tacrolimus Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 29 Japan Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 30 Japan Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 31 China Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 32 China Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 33 Rest of Asia Pacific Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 34 Rest of Asia Pacific Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 35 Latin America Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 36 Latin America Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 37 Latin America Tacrolimus Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 38 Brazil Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 39 Brazil Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 40 Mexico Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 41 Mexico Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 42 Rest of Latin America Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 43 Rest of Latin America Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 44 Middle East & Africa Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 45 Middle East & Africa Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 46 Middle East & Africa Tacrolimus Market Value, by Country, 2018 - 2027 (US$ Mn)

TABLE 47 GCC Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 48 GCC Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 49 Rest of MEA Tacrolimus Market Value, by Clinical Application, 2018 - 2027 (US$ Mn)

TABLE 50 Rest of MEA Tacrolimus Market Value, by Distribution Channel, 2018 - 2027 (US$ Mn)

TABLE 51 Astellas Pharma, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 52 Mylan Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 53 GlaxoSmithKline, Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 54 Glenmark Pharmaceuticals Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 55 Teva Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 56 F.Hoffman La-Roche: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 57 Dr. Reddy’s Laboratories Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 58 Sandoz, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 59 Chiesi Farmaceutici.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

TABLE 60 Abbott Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)

To know more about the study, request sample papers

List of Figures:

FIG. 1 Global Tacrolimus: Market Segmentation

FIG. 2 Global Tacrolimus Market: Research Methodology

FIG. 3 Top-Down and Bottom-up Approach

FIG. 4 Global Tacrolimus Market, by Clinical Application, 2019 (US$ Mn)

FIG. 5 Global Tacrolimus Market, by Distribution Channel, 2019 (US$ Mn)

FIG. 6 Global Tacrolimus Market, by Geography, 2019 (US$ Mn)

FIG. 7 Global Tacrolimus Market Value and Growth, 2018 – 2027, (US$ Mn) (Y-o-Y %)

FIG. 8 Attractive Investment Proposition, by Geography, 2017

FIG. 9 Market Positioning of Key Tacrolimus Providers, 2019

FIG. 10 Global Tacrolimus Market Value Share, by Clinical Application, 2018 & 2027 (%)

FIG. 11 Global Tacrolimus Market Value for Immunosuppressant, 2018 - 2027, (US$ Mn)

FIG. 12 Global Tacrolimus Market Value for Dermatology, 2018 - 2027, (US$ Mn)

FIG. 13 Global Tacrolimus Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 14 Global Tacrolimus Market Value Share, by Distribution Channel, 2018 & 2027 (Value %)

FIG. 15 Global Tacrolimus Market Value for Hospital Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 16 Global Tacrolimus Market Value for Retail Pharmacy, 2018 - 2027, (US$ Mn)

FIG. 17 Global Tacrolimus Market Value for Others, 2018 - 2027, (US$ Mn)

FIG. 18 North America Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

FIG. 19 Europe Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

FIG. 20 Asia Pacific Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

FIG. 21 LATIN America Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

FIG. 22 Middle East & Africa Tacrolimus Market Value, 2018 - 2027, (US$ Mn)

Fill the given form to inquiry before buying for Tacrolimus Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample

Inquiry Before Buying

Schedule a Call

Select License Type

$ 3600/- Single User License
$ 6995/- Corporate License